SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000089
Filing Date
2024-02-22
Accepted
2024-02-22 18:30:54
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5724
  Complete submission text file 0001610717-24-000089.txt   7200
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Rosenbaum David P. (Reporting) CIK: 0001611311 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 24666635